Active, Not Recruiting
A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer
NCT06747338
- Conditions
- Early or Locally Advanced HER2-positive Breast Cancer
- Locations
-
- Clinical Trials Information Group Shanghai, China